Extrawell Pharmaceutical Holdings Limited (00858) has announced that its board of directors will convene on 28 November 2025. The primary agenda is to review and approve the interim results of the company and its subsidiaries for the six months ended 30 September 2025, alongside other business matters as needed. The announcement is dated 13 November 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.